Spots Global Cancer Trial Database for Phase I Study of Indibulin in Patients With Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase I Study of Indibulin in Patients With Solid Tumors
Official Title: Dose-finding and Pharmacokinetic Trial of Orally Administered D-24851 to Patients With Solid Tumors
Study ID: NCT00591136
Conditions
Interventions
Study Description
Brief Summary: Dose-finding and pharmacokinetic trial of orally administered Indibulin to patients with solid tumors.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Amsterdam, , Netherlands
, Utrecht, , Netherlands
Contact Details
Name: Jonathan Lewis, MD, PhD
Affiliation: ZIOPHARM Oncology, Inc
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
